[New prospects in the treatment of non-small-cell lung carcinoma (NSCLC): new biological factors].
Douillard
J Y
JY
Service d'oncologie, Centre René Gauducheau, St-Herblain.
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D004815:Epidermal Growth Factor / Q000037:antagonists & inhibitors / Q000502:physiology; D066246:ErbB Receptors / Q000187:drug effects / Q000502:physiology; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors; D009389:Neovascularization, Pathologic; D009930:Organic Chemicals; D017239:Paclitaxel / Q000008:administration & dosage; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D012106:Research; D013997:Time Factors
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D009930:Organic Chemicals; C113282:prinomastat; D004815:Epidermal Growth Factor; D016190:Carboplatin; D066246:ErbB Receptors; D008666:Metalloendopeptidases; D017239:Paclitaxel
Nouvelles perspectives pour le traitement des cancers bronchiques non à petites cellules (CBNPC): les nouveaux facteurs biologiques.